The urodynamic effects of intravenous opioids and ketoprofen in humans

Anesthesia and Analgesia

Volumn 87, Issue 2, 1998, Pages 456-461

  Malinovsky, J M ^a   Le Normand, L ^a   Lepage, J Y ^a   Malinge, M ^a   Cozian, A ^a   Pinaud, M ^a   Buzelin, J M ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; FENTANYL; KAPPA OPIATE RECEPTOR AGONIST; KETOPROFEN; MORPHINE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALBUPHINE; SODIUM CHLORIDE;

ADULT; ANALGESIA; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR MUSCLE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOSCOPIC SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; URETER STONE; URETHRA PRESSURE; URODYNAMICS;

ADULT; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUPRENORPHINE; FENTANYL; HUMANS; INFUSIONS, INTRAVENOUS; KETOPROFEN; MALE; MIDDLE AGED; MORPHINE; NALBUPHINE; NARCOTIC ANTAGONISTS; URETHRA; URINARY BLADDER; URINATION; URODYNAMICS;

EID: 0031825588     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199808000-00042     Document Type: Article

References (22)

1. Tammela T, Kontturi M, Lukkarinen O. Postoperative urinary retention. I. Incidence and predisposing factors. Scand J Urol Nephrol 1986;20:197-201.
2. Petros JG, Rimm EB, Robillard RJ. Factors influencing urinary tract retention after elective open cholecystectomy. Surgery 1992;174:497-500.
3. Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-replacement surgery. N Engl J Med 1988;319:321-6.
4. Axelsson K, Möllefors K, Olsson JO, et al. Bladder function in spinal anaesthesia. Acta Anaesthesiol Scand 1985;29:315-21.
5. Rawal N, Möllefors K, Axelsson K, et al. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal. Anesth Analg 1983;62:641-7.
6. Hodsman NBA, Kenny GNC, McArdle CS. Patient controlled analgesia and urinary retention. Br J Surg 1988;75:212.
7. Stallard S, Prescott S. Postoperative urinary retention in general surgical patients. Br J Surg 1988;75:1141-3.
8. Murray K. Acute urinary retention associated with sublingual buprenorphine. BMJ 1983;286:763-4.
9. Hommeril JL, Bernard JM, Gouin F, Pinaud M. Ketoprofen for pain after hip and knee arthroplasty. Br J Anaesth 1994;72:383-7.
10. Sandhu DPS, lacovou JW, Fletcher MS, et al. A comparison of intramuscular ketorolac and pethidine in the alleviation of renal colic. Br J Urol 1994;74:690-3.
11. Cole RS, Fry CH, Shuttleworth KED. The action of the prostaglandins on isolated human ureteric smooth muscle. Br J Urol 1988;61:19-26.
12. Olsen UB, Magnussen MP, Eilertsen E. Prostaglandins, a link between renal hydro- and haemodynamics in dogs. Acta Physiol Scand 1976;97:369-76.
13. Doyle PT, Briscoe CE. The effects of drugs and anaesthetic agents on the urinary bladder and sphincters. Br J Urol 1976;48: 329-35.
14. Bailey PL, Stanley TH. Narcotic intravenous anesthetics. In: Miller RD, ed. Anesthesia. 3rd ed. New York: Churchill Livingstone, 1990:281-366.
15. Durant PAC, Yaksh TL. Drug effects on urinary bladder tone during spinal morphine-induced inhibition of the micturition reflex in unanesthetized rats. Anesthesiology 1988;68:325-34.
16. Jaffe JH, Martin WR. Narcotic analgesics and antagonists. In: Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. 5th ed. New York: MacMillan, 1975:245-83.
17. Dray A, Metsch R. Morphine and the centrally-mediated inhibition of urinary bladder motility in the rat. Brain Res 1984;297: 191-5.
18. Dray A, Metsch R. Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids. J Pharmacol Exp Ther 1984;231:254-60.
19. Grell FL, Koons RA, Denson JS. Fentanyl in anesthesia: a report of 500 cases. Anesth Analg 1970;49:523-32.
20. Sheldon RJ, Nunan L, Porreca F. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. J Pharmacol Exp Ther 1987;243:234-40.
21. Sheldon RJ, Nunan L, Porreca F. U50,488H differentially antagonizes the bladder effects of μ agonists at spinal sites. Eur J Pharmacol 1988;146:229-35.
22. Zwergel UE, Zwergel TBH, Neisius DA, Ziegler M. Effects of prostaglandin synthetase inhibitors on the upper urinary tract: experimental studies on isolated preparations and urodynamic measurements in men. Urol Res 1990;18:429-33.